C227H288F12N32O27S — CID 160637547
(2S)-N-[4-[(2S,3R)-4-(4-benzylpiperazin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-2-cyclohexyl-4-(2-ethylpyrazol-3-yl)-4-oxobutanamide;N-[(1S)-3-[4-[(2S)-4-(4-benzylpiperazin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-2-ethylpyrazole-3-carboxamide;(2S)-5-(3-cyanophenyl)-2-cyclohexyl-5,5-difluoro-N-[2-fluoro-4-[(2S,3R)-4-(4-hydroxy-4-methylpiperidin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-4-oxopentanamide;(2S)-5-(3-cyanophenyl)-2-cyclohexyl-5,5-difluoro-N-[2-fluoro-4-[(2S,3R)-4-oxo-3-(propanoylamino)-4-[4-(pyridin-2-ylmethyl)piperazin-1-yl]butan-2-yl]phenyl]-4-oxopentanamide;(2S)-5-(3-cyanophenyl)-2-cyclohexyl-N-[4-[(2S,3R)-4-(1,1-dioxo-1,4-thiazinan-4-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-5,5-difluoro-4-oxopentanamide;(2S)-2-cyclohexyl-4-(2-ethylpyrazol-3-yl)-N-[2-fluoro-4-[(2S,3R)-4-oxo-3-(propanoylamino)-4-(4-propan-2-ylpiperazin-1-yl)butan-2-yl]phenyl]-4-oxobutanamide (PubChem CID 160637547) has the molecular formula C227H288F12N32O27S and a molecular weight of 4157.04 g/mol. Its IUPAC name is (2S)-N-[4-[(2S,3R)-4-(4-benzylpiperazin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-2-cyclohexyl-4-(2-ethylpyrazol-3-yl)-4-oxobutanamide;N-[(1S)-3-[4-[(2S)-4-(4-benzylpiperazin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-2-ethylpyrazole-3-carboxamide;(2S)-5-(3-cyanophenyl)-2-cyclohexyl-5,5-difluoro-N-[2-fluoro-4-[(2S,3R)-4-(4-hydroxy-4-methylpiperidin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-4-oxopentanamide;(2S)-5-(3-cyanophenyl)-2-cyclohexyl-5,5-difluoro-N-[2-fluoro-4-[(2S,3R)-4-oxo-3-(propanoylamino)-4-[4-(pyridin-2-ylmethyl)piperazin-1-yl]butan-2-yl]phenyl]-4-oxopentanamide;(2S)-5-(3-cyanophenyl)-2-cyclohexyl-N-[4-[(2S,3R)-4-(1,1-dioxo-1,4-thiazinan-4-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-5,5-difluoro-4-oxopentanamide;(2S)-2-cyclohexyl-4-(2-ethylpyrazol-3-yl)-N-[2-fluoro-4-[(2S,3R)-4-oxo-3-(propanoylamino)-4-(4-propan-2-ylpiperazin-1-yl)butan-2-yl]phenyl]-4-oxobutanamide.
| Compound Name | (2S)-N-[4-[(2S,3R)-4-(4-benzylpiperazin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-2-cyclohexyl-4-(2-ethylpyrazol-3-yl)-4-oxobutanamide;N-[(1S)-3-[4-[(2S)-4-(4-benzylpiperazin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-2-ethylpyrazole-3-carboxamide;(2S)-5-(3-cyanophenyl)-2-cyclohexyl-5,5-difluoro-N-[2-fluoro-4-[(2S,3R)-4-(4-hydroxy-4-methylpiperidin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-4-oxopentanamide;(2S)-5-(3-cyanophenyl)-2-cyclohexyl-5,5-difluoro-N-[2-fluoro-4-[(2S,3R)-4-oxo-3-(propanoylamino)-4-[4-(pyridin-2-ylmethyl)piperazin-1-yl]butan-2-yl]phenyl]-4-oxopentanamide;(2S)-5-(3-cyanophenyl)-2-cyclohexyl-N-[4-[(2S,3R)-4-(1,1-dioxo-1,4-thiazinan-4-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-5,5-difluoro-4-oxopentanamide;(2S)-2-cyclohexyl-4-(2-ethylpyrazol-3-yl)-N-[2-fluoro-4-[(2S,3R)-4-oxo-3-(propanoylamino)-4-(4-propan-2-ylpiperazin-1-yl)butan-2-yl]phenyl]-4-oxobutanamide |
|---|---|
| PubChem CID | 160637547 |
| Molecular Formula | C227H288F12N32O27S |
| Molecular Weight | 4157.04 g/mol |
| Exact Mass | 4154.17 |
| IUPAC Name | (2S)-N-[4-[(2S,3R)-4-(4-benzylpiperazin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-2-cyclohexyl-4-(2-ethylpyrazol-3-yl)-4-oxobutanamide;N-[(1S)-3-[4-[(2S)-4-(4-benzylpiperazin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-1-(4-methylcyclohexyl)-2-oxopropyl]-2-ethylpyrazole-3-carboxamide;(2S)-5-(3-cyanophenyl)-2-cyclohexyl-5,5-difluoro-N-[2-fluoro-4-[(2S,3R)-4-(4-hydroxy-4-methylpiperidin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]-4-oxopentanamide;(2S)-5-(3-cyanophenyl)-2-cyclohexyl-5,5-difluoro-N-[2-fluoro-4-[(2S,3R)-4-oxo-3-(propanoylamino)-4-[4-(pyridin-2-ylmethyl)piperazin-1-yl]butan-2-yl]phenyl]-4-oxopentanamide;(2S)-5-(3-cyanophenyl)-2-cyclohexyl-N-[4-[(2S,3R)-4-(1,1-dioxo-1,4-thiazinan-4-yl)-4-oxo-3-(propanoylamino)butan-2-yl]-2-fluorophenyl]-5,5-difluoro-4-oxopentanamide;(2S)-2-cyclohexyl-4-(2-ethylpyrazol-3-yl)-N-[2-fluoro-4-[(2S,3R)-4-oxo-3-(propanoylamino)-4-(4-propan-2-ylpiperazin-1-yl)butan-2-yl]phenyl]-4-oxobutanamide |
| SMILES | CCC(=O)NC(C(=O)N1CCN(Cc2ccccc2)CC1)[C@@H](C)c1ccc(CC(=O)[C@@H](NC(=O)c2ccnn2CC)C2CCC(C)CC2)c(F)c1.CCC(=O)N[C@@H](C(=O)N1CCC(C)(O)CC1)[C@@H](C)c1ccc(NC(=O)C(CC(=O)C(F)(F)c2cccc(C#N)c2)C2CCCCC2)c(F)c1.CCC(=O)N[C@@H](C(=O)N1CCN(C(C)C)CC1)[C@@H](C)c1ccc(NC(=O)[C@@H](CC(=O)c2ccnn2CC)C2CCCCC2)c(F)c1.CCC(=O)N[C@@H](C(=O)N1CCN(Cc2ccccc2)CC1)[C@@H](C)c1ccc(NC(=O)[C@@H](CC(=O)c2ccnn2CC)C2CCCCC2)c(F)c1.CCC(=O)N[C@@H](C(=O)N1CCN(Cc2ccccn2)CC1)[C@@H](C)c1ccc(NC(=O)[C@@H](CC(=O)C(F)(F)c2cccc(C#N)c2)C2CCCCC2)c(F)c1.CCC(=O)N[C@@H](C(=O)N1CCS(=O)(=O)CC1)[C@@H](C)c1ccc(NC(=O)C(CC(=O)C(F)(F)c2cccc(C#N)c2)C2CCCCC2)c(F)c1 |
| InChI | InChI=1S/C41H47F3N6O4.C40H53FN6O4.C39H51FN6O4.C37H45F3N4O5.C35H41F3N4O6S.C35H51FN6O4/c1-3-37(52)48-38(40(54)50-20-18-49(19-21-50)26-32-14-7-8-17-46-32)27(2)30-15-16-35(34(42)23-30)47-39(53)33(29-11-5-4-6-12-29)24-36(51)41(43,44)31-13-9-10-28(22-31)25-45;1-5-36(49)43-37(40(51)46-22-20-45(21-23-46)26-29-10-8-7-9-11-29)28(4)31-16-17-32(33(41)24-31)25-35(48)38(30-14-12-27(3)13-15-30)44-39(50)34-18-19-42-47(34)6-2;1-4-36(48)43-37(39(50)45-22-20-44(21-23-45)26-28-12-8-6-9-13-28)27(3)30-16-17-33(32(40)24-30)42-38(49)31(29-14-10-7-11-15-29)25-35(47)34-18-19-41-46(34)5-2;1-4-32(46)43-33(35(48)44-17-15-36(3,49)16-18-44)23(2)26-13-14-30(29(38)20-26)42-34(47)28(25-10-6-5-7-11-25)21-31(45)37(39,40)27-12-8-9-24(19-27)22-41;1-3-31(44)41-32(34(46)42-14-16-49(47,48)17-15-42)22(2)25-12-13-29(28(36)19-25)40-33(45)27(24-9-5-4-6-10-24)20-30(43)35(37,38)26-11-7-8-23(18-26)21-39;1-6-32(44)39-33(35(46)41-19-17-40(18-20-41)23(3)4)24(5)26-13-14-29(28(36)21-26)38-34(45)27(25-11-9-8-10-12-25)22-31(43)30-15-16-37-42(30)7-2/h7-10,13-17,22-23,27,29,33,38H,3-6,11-12,18-21,24,26H2,1-2H3,(H,47,53)(H,48,52);7-11,16-19,24,27-28,30,37-38H,5-6,12-15,20-23,25-26H2,1-4H3,(H,43,49)(H,44,50);6,8-9,12-13,16-19,24,27,29,31,37H,4-5,7,10-11,14-15,20-23,25-26H2,1-3H3,(H,42,49)(H,43,48);8-9,12-14,19-20,23,25,28,33,49H,4-7,10-11,15-18,21H2,1-3H3,(H,42,47)(H,43,46);7-8,11-13,18-19,22,24,27,32H,3-6,9-10,14-17,20H2,1-2H3,(H,40,45)(H,41,44);13-16,21,23-25,27,33H,6-12,17-20,22H2,1-5H3,(H,38,45)(H,39,44)/t27-,33-,38+;27?,28-,30?,37?,38-;27-,31-,37+;23-,28?,33+;22-,27?,32+;24-,27-,33+/m000000/s1 |
| InChIKey | RISUOJPMHXZFEZ-HWNCYHFBSA-N |
| XLogP | 33.03 |
| TPSA | 778.53 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 41 |
| Rotatable Bonds | 79 |
| Heavy Atoms | 299 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4157.04 |
| LogP ≤ 5 | 33.03 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 41 |